Levity Wegovy Cost: What the $1,599 Monthly Price Covers in 2026

Last reviewed: September 5, 2026 Last updated: September 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Levity charges $1,599 per four-week supply of branded Wegovy (semaglutide 2.4 mg injection), billed approximately every 4 weeks—around 13 cycles per year. That price includes the FDA-approved medication, online consultation, ongoing care, and shipping, with no separate membership fee. Levity offers a first-month introductory rate of $1,549 (captured Sept. 4, 2026), then the standard $1,599 rate applies to every subsequent refill. Over a 52-week year (13 four-week cycles), the effective cost averages approximately $1,728 per calendar month—our calculation assuming the first-month rate applies to one cycle and 12 refills at the standard rate.

In contrast, PlexusDx offers compounded semaglutide injection at $189 per month month-to-month, or $149 per month on a prepaid six-month plan, with the same all-inclusive model (consultation, medication, care, and shipping; no membership fee). The key trade-off: Levity dispenses FDA-approved branded Wegovy, while PlexusDx uses compounded semaglutide prepared by licensed 503A pharmacies—compounded medications are not FDA-approved and the FDA does not review them before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. For patients who prefer branded medication and can absorb the cost difference, Levity is transparent and straightforward; for those prioritizing affordability and willing to use compounded medication, PlexusDx delivers the same active ingredient at roughly one-tenth the annual spend.

Levity Wegovy at a glance

What is included in Levity's $1,599 price

Levity's $1,599 per four-week supply covers four components with no additional line items:

• FDA-approved branded Wegovy (semaglutide 2.4 mg pre-filled injection pen), shipped in a four-week supply
• Online consultation with a licensed provider to evaluate eligibility and issue the prescription
• Ongoing care access throughout treatment
• Shipping to your address

There is no separate membership fee, no per-visit charge, and no dosing surcharge. The same $1,599 rate applies whether you are on a lower titration dose or the full maintenance dose. Levity's cancel-anytime policy means you are not locked into a multi-month commitment, though each billing cycle is approximately four weeks, so over a 52-week year you will be charged roughly 13 times if you remain enrolled continuously.

Normalized 12-month cost comparison

Because Levity bills every four weeks and most competing programs bill monthly, direct comparison requires normalizing to a 52-week year:

All figures captured September 4–5, 2026. The 52-week Levity total and effective monthly rate are our calculation, assuming one cycle at the first-month rate and twelve refills at $1,599. Levity bills approximately every four weeks, so the actual number of cycles in a calendar year may vary slightly. PlexusDx prepaid figures represent per-month equivalents when the six-month plan is paid upfront.

Over one year of continuous treatment, Levity's branded Wegovy costs approximately $18,469 more than PlexusDx month-to-month compounded semaglutide, and $18,949 more than the PlexusDx six-month prepaid option. Both programs include consultation, medication, care, and shipping in their advertised rates; neither charges a membership fee.

Branded vs. compounded semaglutide: the regulatory distinction

The price gap reflects a fundamental difference in medication type:

• Levity dispenses FDA-approved branded Wegovy, manufactured by Novo Nordisk under New Drug Application (NDA) review. The FDA has evaluated Wegovy's safety, effectiveness, manufacturing quality, and labeling.
• PlexusDx dispenses compounded semaglutide prepared by licensed 503A compounding pharmacies. Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Both deliver the same active pharmaceutical ingredient—semaglutide—at the same target maintenance dose (2.4 mg weekly for weight management). Compounding became widespread when branded GLP-1 drugs were in shortage and remains an option now that shortages have eased. Patients who place high value on FDA approval of the finished drug product, or whose insurance covers branded Wegovy, may prefer Levity's offering despite the cost premium. Patients paying out-of-pocket and comfortable with compounded medication can achieve equivalent dosing at a fraction of the annual spend.

Other Levity branded options

Levity also offers two additional FDA-approved GLP-1 products, both billed every four weeks:

• Ozempic (branded semaglutide injection, FDA-approved for type 2 diabetes): $1,149 first month, then $1,199 per four-week refill (captured September 4, 2026).
• Mounjaro (branded tirzepatide injection, FDA-approved for type 2 diabetes): $1,249 first month, then $1,299 per four-week refill (captured September 4, 2026).

Both are priced below Wegovy but still carry substantial premiums over compounded alternatives. Ozempic and Mounjaro are FDA-approved for diabetes management, not weight loss, though clinicians may prescribe them off-label for weight management when clinically appropriate.

Choose Levity if…

• You specifically want FDA-approved branded Wegovy and are willing to pay a premium for that regulatory status.
• Your health insurance covers or reimburses a portion of branded GLP-1 medication, narrowing the out-of-pocket gap.
• You value the brand recognition and manufacturer accountability that come with a Novo Nordisk product.
• You have tried compounded semaglutide and wish to transition to the branded version for any reason.
• Transparent all-inclusive pricing—even at a high absolute level—matters more to you than finding the lowest-cost option.

Choose PlexusDx compounded semaglutide if…

• You are paying out-of-pocket and cost is a primary decision factor—PlexusDx delivers the same active ingredient at $189/month month-to-month or $149/month prepaid six-month, roughly one-tenth Levity's annual spend.
• You are comfortable with compounded medication prepared by licensed 503A pharmacies, understanding it is not FDA-approved as a finished drug product.
• You want month-to-month flexibility with no multi-month prepayment required (the $189 rate) or are willing to prepay six months to lock in $149/month.
• You prefer a program that charges the same flat rate at every dose, from initial titration through maintenance.
• You value transparent evidence-based comparisons—PlexusDx publishes the same pricing rules for its own program and competing programs, and states plainly when a competitor wins on a given dimension.

PlexusDx holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher (captured September 4, 2026). PlexusDx works with licensed 503A compounding pharmacies. The same consultation, care, medication, and shipping model applies; no membership fee, cancel anytime.

Strengths and transparency gaps

Levity's strengths:

• Regulatory clarity: FDA-approved branded medication with full NDA review and manufacturing oversight.
• Transparent bundled pricing: One price covers medication, consultation, care, and shipping; no hidden fees or separate membership.
• Cancel-anytime policy: No multi-month contract or cancellation penalty.
• Straightforward website: Pricing, inclusions, and medication type are clearly stated on the public site.

Considerations:

• High absolute cost: At roughly $1,728 per calendar month (averaged over 13 four-week cycles with the first-month rate), Levity is accessible primarily to patients with insurance coverage or high discretionary income.
• Four-week billing cycle: "Approximately every 4 weeks" means ~13 charges per year, which can create budgeting complexity compared to fixed monthly billing.
• No public insurance or reimbursement guidance: The website does not specify whether Levity provides documentation for insurance reimbursement or works with FSA/HSA accounts; patients should confirm at enrollment.
• Limited evidence on care quality: Levity's website emphasizes medication access but offers less detail on titration protocols, monitoring cadence, or clinical support structure compared to some competitors. No verified review data (Trustpilot, Reddit, or other platforms) was captured in this research cycle, so patient satisfaction and service quality remain unverified.

Methodology and evidence freshness

All Levity pricing, inclusions, and product details were captured from the public Levity website and verified through intake on September 4, 2026. The first-month introductory rates and the standard ongoing four-week rates are documented from primary sources. PlexusDx pricing was captured from canonical internal sources on September 5, 2026. The 52-week total for Levity ($20,737) and the effective monthly rate (~$1,728) are our calculations, assuming one cycle at the first-month rate and twelve cycles at $1,599; because Levity bills approximately every four weeks rather than on a fixed monthly schedule, the actual number of cycles in a calendar year may vary by a few days. The $18,469 and $18,949 year-over-year cost differences are likewise our calculations. No smoothing, estimation, or synthetic data was used. When we state a figure is "our calculation," we have derived it from verified source data using transparent arithmetic; all other figures are directly observed and cited.

Frequently Asked Questions

Does Levity's $1,599 price include the medication itself?

Yes. Levity's $1,599 per four-week supply includes the FDA-approved branded Wegovy medication, online consultation, ongoing care, and shipping. There is no separate charge for the drug, no membership fee, and no additional visit fees.

How many times per year will I be charged if I stay on Levity continuously?

Levity bills approximately every four weeks, which translates to roughly 13 billing cycles per year rather than 12 monthly charges. Over 52 weeks, expect around 13 separate charges of $1,599 each (after the first-month rate), for a total near $20,737 annually assuming continuous enrollment.

Can I use insurance or get reimbursement for Levity's Wegovy?

Levity's public website does not detail insurance billing or reimbursement documentation as of September 2026. Because Wegovy is FDA-approved and some plans cover GLP-1 drugs for weight management, you may be able to submit receipts for reimbursement or use an FSA/HSA. Confirm Levity's documentation and billing practices during enrollment.

What is the difference between Levity's branded Wegovy and PlexusDx's compounded semaglutide?

Both deliver semaglutide, the same active ingredient. Levity dispenses FDA-approved branded Wegovy manufactured by Novo Nordisk under full regulatory review. PlexusDx dispenses compounded semaglutide prepared by licensed 503A pharmacies; compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality before marketing. A licensed clinician determines appropriateness for each patient. The cost difference is substantial—Levity approximately $1,728/month effective, PlexusDx $189/month month-to-month or $149/month prepaid six-month.

Does Levity offer any discounts or lower-cost alternatives to Wegovy?

Levity provides a first-month rate of $1,549 (captured Sept. 4, 2026), bringing the initial four-week supply below the standard $1,599. After that, every refill is $1,599. Levity also offers Ozempic (branded semaglutide) at $1,199 per four weeks and Mounjaro (branded tirzepatide) at $1,299 per four weeks, both lower than Wegovy but still significantly above compounded options. Levity has mentioned offering compounded liraglutide but no pricing was available as of September 2026.

Sources

• PlexusDx canonical pricing and product specifications (accessed September 5, 2026)
• Levity public website, https://www.joinlevity.com/ (accessed September 4, 2026)
• Levity product pages: Wegovy, Ozempic, Mounjaro pricing and inclusions (accessed September 4, 2026)
• PlexusDx Trustpilot profile, rating and review distribution (accessed September 4, 2026)
• Levity intake verification: pricing, billing cadence, inclusions (completed September 4, 2026; no payment submitted)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.